Patents by Inventor Anne Rousseau

Anne Rousseau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6844445
    Abstract: Compound of formula (I): wherein: R represents hydrogen or a group selected from alkenyl and optionally substituted alkyl, each of R1 to R8, which may be identical or different, represents hydrogen or a group selected from alkyl, alkenyl, hydroxy, alkoxy, alkenyloxy, arylalkyl, arylalkoxy, carboxy, acyloxy and arylcarbonyloxy, or one of R1 to R8 forms with an adjacent one R1 to R8 an alkylenedioxy group, its optical isomers when they exist, and addition salts thereof with a pharmaceutically acceptable acid or base, with the proviso that: when R does not represent hydrogen, then at least one of R1 to R8 represents hydroxy or acyloxy, and the compounds of formula (I) are other than indeno[1,2-b]indol-10(5H)-one and medicinal products containing the same which are useful for treatment of disorders of the melatoninergic system.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: January 18, 2005
    Assignee: Les Laboratoires Servier
    Inventors: Michel Wierzbicki, Marie-Françoise Boussard, Anne Rousseau, Jean Albert Boutin, Philippe Delagrange
  • Patent number: 6627650
    Abstract: A compound of formula (I): wherein: R represents hydrogen, optionally substituted alkyl or alkenyl, R1 to R8, which may be identical or different, each represents hydrogen, optionally substituted alkyl, hydroxy, acyloxy, optionally substituted amino, carboxy, optionally substituted alkoxy, or alkenyloxy, or one of R1 to R8 forms, with another of R1 to R8 that is adjacent, an alkylenedioxy group, X represents oxygen or NR16 wherein R16 represents hydrogen, alkyl, aryl or arylalkyl, R9 represents hydrogen, aryl, heteroaryl, or optionally substituted, saturated or unsaturated alkyl, an isomer thereof, or an addition salt thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti-cancer agents.
    Type: Grant
    Filed: June 13, 2002
    Date of Patent: September 30, 2003
    Assignee: Les Laboratoires Servier
    Inventors: Michel Wierzbicki, Marie-Françoise Boussard, Anne Rousseau, Ghanem Atassi, John Hickman, Alain Pierre, Stéphane Leonce, Nicolas Guilbaut, Laurence Kraus-Berthier
  • Publication number: 20030125369
    Abstract: Compound of formula (I): 1
    Type: Application
    Filed: June 13, 2002
    Publication date: July 3, 2003
    Inventors: Michel Wierzbicki, Marie-Francoise Boussard, Anne Rousseau, Ghanem Atassi, John Hickman, Alain Pierre, Stephane Leonce, Nicolas Guilbaud, Laurence Kraus-Berthier
  • Publication number: 20020173531
    Abstract: Compound of formula (I): 1
    Type: Application
    Filed: March 19, 2002
    Publication date: November 21, 2002
    Inventors: Michel Wierzbicki, Marie-Francoise Boussard, Anne Rousseau, Jean Albert Boutin, Philippe Delagrange
  • Patent number: 6465660
    Abstract: Compound of formula (I): wherein: R1, R2, R3, R4, R5, R6 and R8, which may be identical or different, each represents hydrogen, alkyl, arylalkyl, hydroxy, alkoxy, arylalkoxy, acyloxy, arylcarbonyloxy, carboxyalkyl or carboxy, R7 represents hydrogen, hydroxy, alkoxy, arylalkoxy, acyloxy or arylcarbonyloxy group, or one of R1 to R8, together with another of R1 to R8 adjacent to it, forms an alkylenedioxy, its optical isomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: October 15, 2002
    Assignee: Les Laboratoires Servier
    Inventors: Michel Wierzbicki, Marie-Françoise Boussard, Anne Rousseau, Jean Albert Boutin, Philippe Delagrange